Our expertise
The FemTech Research Hub brings deep, sector-specific capability across the four technology classes that dominate the modern FemTech market.
Diagnostics
- Diagnostic accuracy studies
- Biomarker validation
- Point-of-care test evaluation
- AI-powered diagnostic platform validation.
The EVE Clinical Network provides tissue and sample access for endometriosis, fibroids, PCOS, and broader reproductive health diagnostics, supported by EVIE's diagnostic test accuracy review methodology.
Pharmaceuticals
- Phase II-IV clinical trials
- Real-world drug effectiveness studies
- Repurposing studies for women's health indications
- Evidence synthesis for licensing extensions, with particular depth in fertility, hormonal therapies, contraception, and menopause care.
Medical devices
- Pre-market clinical investigations
- Post-market clinical follow-up (PMCF)
- Comparative effectiveness research
- Human-factors and usability studies, spanning Class I to Class III devices and combination products under both EU MDR and UK MDR routes
AI applications and health informatics
- Algorithm validation
- Predictive model evaluation
- Software as a medical device (SaMD) regulatory support
- Real-world performance monitoring
- Bias and equity audits.
We work across maternal AI, reproductive predictive models, fertility algorithms, and digital therapeutics for menopause and menstrual health.